Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Gubens

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Current Treatment Options in Oncology|September 11, 2012
Treatment updates in advanced thymoma and thymic carcinomaMatthew A Gubens
Journal of the National Comprehensive Cancer Network : JNCCN|May 19, 2017
Immunotherapies for Lung CancerMatthew A Gubens
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2019
NCCN Guidelines Updates: New Immunotherapy Strategies for Improving Outcomes in Non-Small Cell Lung CancerMatthew A Gubens, Marianne Davies
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Docetaxel in the treatment of non-small cell lung carcinoma: an update and analysisMatthew A Gubens, Heather A Wakelee
Clinics in Chest Medicine|November 8, 2011
Current management of small cell lung cancerJoel W Neal, Matthew A Gubens, Heather A Wakelee
JCO Precision Oncology|August 29, 2024
Real-World Biomarker Test Ordering Practices in Non-Small Cell Lung Cancer: Interphysician Variation and Association With Clinical OutcomesJason M Baron, Sarrah Widatalla, Matthew A Gubens, et al.
JCO Precision Oncology|February 9, 2022
ALK Testing Trends and Patterns Among Community Practices in the United StatesPeter B Illei, William Wong, Ning Wu, et al.
Pancreas|August 4, 2018
Long-Term Survivors of Pancreatic Cancer: A California Population-Based StudyAdel Kardosh, Daphne Y Lichtensztajn, Matthew A Gubens, et al.
Journal of the American College of Cardiology|March 19, 2004
Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fractionPaul A Heidenreich, Matthew A Gubens, Gregg C Fonarow, et al.
Clinical Lung Cancer|February 15, 2014
Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment eraJonathan W Riess, Seema Nagpal, Michael Iv, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Current Treatment Options in Oncology|September 11, 2012
Treatment updates in advanced thymoma and thymic carcinomaMatthew A Gubens
Journal of the National Comprehensive Cancer Network : JNCCN|May 19, 2017
Immunotherapies for Lung CancerMatthew A Gubens
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2019
NCCN Guidelines Updates: New Immunotherapy Strategies for Improving Outcomes in Non-Small Cell Lung CancerMatthew A Gubens, Marianne Davies
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Docetaxel in the treatment of non-small cell lung carcinoma: an update and analysisMatthew A Gubens, Heather A Wakelee
Clinics in Chest Medicine|November 8, 2011
Current management of small cell lung cancerJoel W Neal, Matthew A Gubens, Heather A Wakelee
JCO Precision Oncology|August 29, 2024
Real-World Biomarker Test Ordering Practices in Non-Small Cell Lung Cancer: Interphysician Variation and Association With Clinical OutcomesJason M Baron, Sarrah Widatalla, Matthew A Gubens, et al.
JCO Precision Oncology|February 9, 2022
ALK Testing Trends and Patterns Among Community Practices in the United StatesPeter B Illei, William Wong, Ning Wu, et al.
Pancreas|August 4, 2018
Long-Term Survivors of Pancreatic Cancer: A California Population-Based StudyAdel Kardosh, Daphne Y Lichtensztajn, Matthew A Gubens, et al.
Journal of the American College of Cardiology|March 19, 2004
Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fractionPaul A Heidenreich, Matthew A Gubens, Gregg C Fonarow, et al.
Clinical Lung Cancer|February 15, 2014
Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment eraJonathan W Riess, Seema Nagpal, Michael Iv, et al.
Pageof 6